✦ LIBER ✦

558 COST-EFFECTIVENESS SIMULATION ANALYSIS OF TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR), LAMIVUDINE, ADEFOVIR DIPIVOXIL (ADEFOVIR) AND ENTECAVIR OF HBEAG NEGATIVE (-) PATIENTS WITH CHRONIC HEPATITIS-B (CHB) IN SPAIN

✍ Scribed by B. Deniz; M. Buti; M. Brosa; M.A. Casado; M. Rueda; F. Everhard; R. Esteban

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

559 COST-EFFECTIVENESS SIMULATION ANALYS

✍ B. Deniz; F. Everhard 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Cost-effectiveness analysis of lamivudin

✍ M. BUTI; M. A. CASADO; J. L. CALLEJA; J. SALMERÓN; J. AGUILAR; M. RUEDA; R. ESTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Cost Effectiveness Analysis Of Tenofovir

✍ Soto, H.; Botello, B.S.; Pizarro, M.; Rizzoli, A.; Gozález, L.A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

903 TENOFOVIR DISOPROXIL FUMARATE (TDF)

✍ T. Berg; B. Moller; H. Trinh; S. Chan; P. Marcellin; E. Suarez; A. Snow-Lampart; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 88 KB

322 Tenofovir Disoproxil Fumarate (TDF)

✍ Berg, Thomas; Moeller, Bernd; Trinh, Huy N.; Chan, Sing; Marcellin, Patrick; Sua 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 74 KB

925 SAFETY AND TOLERABILITY OF 96 WEEKS

✍ P. Marcellin; E.J. Heathcote; I. Jacobson; P. Mathurin; E. Gane; P. Buggisch; P. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 161 KB